DEF: Inception Growth Seeks Extension Amid Nasdaq Delisting

Inception Growth Acquisition Limited is seeking stockholder approval to extend its deadline for completing a business combination to February 13, 2027, following its delisting from Nasdaq.

Summary

• Inception Growth Acquisition Limited is holding a Special Meeting of Stockholders on August 12, 2026, to vote on proposals to extend the deadline for consummating a business combination.
• The company proposes to amend its charter and trust agreement to extend the deadline from August 13, 2026, to February 13, 2027, requiring a payment of $0.05 per public share not redeemed for each monthly extension.
• Stockholders will also vote on an adjournment proposal to allow for further proxy solicitation if needed.
• The company's securities were delisted from Nasdaq on December 17, 2024, due to failure to complete a business combination by the required deadline and are now trading on the OTC Markets.
• The redemption price per public share as of July 29, 2026, was approximately $13.57, while the closing price on the OTC Markets was $0.0011.
• The Sponsor, Soul Venture Partners LLC, which owns 42.7% of the shares, will provide loans to fund the extensions, which will be forgiven if a business combination is not completed, except for funds held outside the trust account.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the company's delisting from Nasdaq, the ongoing need for extensions to complete a business combination, and the significant dilution risk for shareholders if a combination is not achieved.

Positives

• The company is actively seeking to extend its timeline to find a suitable business combination, providing more time for potential value creation.
• The Sponsor is willing to provide financial support through loans to fund the monthly extensions, demonstrating a commitment to finding a deal.
• Stockholders have the right to redeem their shares if they do not wish to proceed with the extension, offering an exit strategy.

Negatives

• The company has been delisted from Nasdaq and is now trading on the OTC Markets, significantly reducing liquidity and potentially limiting investor access.
• The company has repeatedly extended its deadline, indicating difficulty in identifying and closing a business combination within the original timeframe.
• The current market price of $0.0011 per share is drastically lower than the approximate redemption value of $13.57 per share, highlighting a significant loss for many shareholders.
• There is a risk that if a business combination is not completed by February 13, 2027, the company will liquidate, and warrants and rights will expire worthless, with public stockholders receiving only the remaining trust account funds.

Risks

• Failure to complete a business combination by February 13, 2027, will result in liquidation and return of funds from the trust account to public stockholders, with warrants and rights expiring worthless.
• The company's delisting from Nasdaq and trading on OTC Markets may lead to limited liquidity, reduced trading activity, and difficulty in obtaining future financing.
• Potential review by CFIUS or other U.S. government entities could delay or prohibit a business combination, especially with a U.S. target company, due to the Sponsor's foreign ownership control.
• There is a risk that the company could be deemed an unregistered investment company under the Investment Company Act of 1940, leading to abandonment of business combination efforts and liquidation.
• The company cannot assure stockholders that they will be able to sell their Public Shares in the open market at or above the redemption price due to potential liquidity issues.

Future Outlook

The company is seeking to extend its business combination deadline to February 13, 2027. If approved, the company will have six additional one-month periods to complete a business combination, funded by sponsor loans of $0.05 per non-redeemed share for each extension. Failure to complete a combination by the extended date will result in liquidation.

Management Comments

• "We hope you can join us."
• "Whether or not you plan to attend, please take the time now to read the Proxy Statement and vote by submitting by mail a paper copy of your proxy or vote instructions, so that your shares are represented at the meeting."
• "Regardless of the number of Company shares you own, your presence in person or by proxy is important for quorum purposes and your vote is important for proper corporate action."
• "The Company believes that such redemption right enables its holders of Public Shares to determine whether to keep their investments for an additional period of time if the Company does not complete a business combination on or before the Current Termination Date."

Industry Context

StockSavvy.ai notes that this filing is typical for Special Purpose Acquisition Companies (SPACs) facing their initial deadline. The repeated extensions and subsequent delisting from major exchanges like Nasdaq are unfortunately common occurrences for SPACs that struggle to find and close a business combination within the mandated timeframe. The shift to OTC markets is a significant indicator of reduced investor confidence and liquidity.

Comparison to Industry Standards

• Most SPACs are required to complete a business combination within 18-24 months of their IPO. Inception Growth Acquisition Limited has already extended its deadline multiple times, now seeking an extension to 62 months from its IPO closing date (December 8, 2021), which is significantly longer than the typical industry standard.
• Nasdaq's IM-5101-2 rule, which mandates a 36-month completion window, is a standard requirement for SPACs listed on the exchange. The company's failure to meet this deadline led to its delisting, a consequence faced by other SPACs that do not meet exchange listing requirements.
• The practice of sponsors providing loans to fund extensions is a common mechanism in the SPAC industry to bridge the gap when the trust account funds are insufficient for monthly extensions. However, the terms of these loans (non-interest bearing, repayable upon business combination, or forgiven if no combination occurs) are critical for assessing sponsor alignment and potential dilution.

Legal Proceedings

• The company received a notice from Nasdaq on December 10, 2024, stating non-compliance with IM-5101-2 and that its securities were subject to delisting.

Related Party Transactions

• The Sponsor, Soul Venture Partners LLC, will provide loans to fund the monthly extensions, which are non-interest bearing and repayable upon consummation of a business combination, or forgiven if no combination is completed (except for funds outside the trust account).

Stakeholder Impact

• Shareholders face significant risk of losing their investment if a business combination is not completed, as they may only receive the pro rata amount from the trust account, which is currently less than the initial investment for many.
• Warrant and rights holders will see their instruments expire worthless if the company liquidates.
• The delisting from Nasdaq and trading on OTC Markets reduces liquidity for all securityholders, making it harder to buy or sell shares.

Next Steps

• Stockholders to vote on the Charter Amendment Proposal, Trust Amendment Proposal, and Adjournment Proposal at the Special Meeting on August 12, 2026.
• If proposals are approved, the company will have until February 13, 2027, to consummate a business combination.
• If proposals are not approved or a business combination is not consummated by the deadline, the company will liquidate and return funds from the trust account to public stockholders.

Key Dates

Recommendation

The company's delisting from Nasdaq, repeated failure to find a business combination, and the significant disparity between the current market price and the redemption value strongly suggest that shareholders should exit their positions. The ongoing extensions, funded by sponsor loans that may be forgiven, indicate a high probability of liquidation rather than a successful merger, leading to a loss of capital for most investors.

Keywords

Special Meeting, Proxy Statement, Business Combination, Extension, Charter Amendment, Trust Agreement, Redemption, SPAC